Project Grant R01NS147497
- Federal Project Grant Award Summary Great Lakes Neurotechnologies Inc. received a $1.13 million Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded August 21, 2025, with completion targeted for June 30, 2027. The grant funds development of DBS-EXPERT PRO, an expert system designed to optimize postoperative programming of Deep Brain Stimulation...
- Federal Project Grant Award Summary Award Overview: The National Institute of Neurological Disorders and Stroke (NINDS) awarded Boston University $465,500 on July 5, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop and validate a close-loop deep brain optoacoustic stimulation (DBOAS) technology through June 30, 2027. The project addresses significant limitations in current electrical deep brain stimulation (DBS)...
- Federal Grant Award Summary Boston University has been awarded $167,384 under the National Institute of Neurological Disorders and Stroke (NINDS) Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to conduct research on the mechanisms of noninvasive ultrasonic neuromodulation of Parkinsonian neural circuits. The award, effective December 1, 2025, and scheduled for completion by December 22, 2027, will support investigational research examining how...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $1,042,170 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025 through August 31, 2033. The award supports computational neuroscience research focused on model-based analysis of brain stimulation and recording...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The University of Texas Southwestern Medical Center a Project Grant totaling $656,879 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025, through July 31, 2030. This award supports research investigating the mechanisms of glioma initiation driven by isocitrate dehydrogenase (IDH) oncogenes. The research...
- Federal Grant Award Summary New York University received a $527,037 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective June 12, 2025, through May 31, 2030. The award funds research investigating neural representation of perceptual decisions, confidence, and actions in human basal ganglia and thalamus. The project leverages recordings...
- Federal Grant Award Summary New York University School of Medicine received a $164,516 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 1, 2025, through April 30, 2027. This award funds research investigating the neural mechanisms underlying speech planning and its relationship to neurological disorders, specifically Parkinson's disease...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Icahn School of Medicine at Mount Sinai a Project Grant of $295,240 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award was obligated on May 1, 2025, with a completion date of April 30, 2027. This research grant funds a two-year investigation titled "Profiling of Midbrain Neuronal Vulnerability in Parkinson's...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $249,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective February 15, 2026, through January 31, 2028. This research initiative will develop and evaluate gene replacement therapy utilizing an adeno-associated virus serotype 9 (AAV9) vector to...
- Federal Project Grant Award Summary The University of Alabama at Birmingham received a $350,036 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, awarded June 18, 2025, with completion targeted for May 31, 2030. The research will investigate epigenetic mechanisms underlying levodopa-induced dyskinesia (LID), a debilitating motor side effect of...
The University of Texas Southwestern Medical Center received a $597,934 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded on March 22, 2026, with a completion date of December 31, 2030. This research project, titled "Dissecting the Network Physiology of Pallidal Burst Stimulation," investigates advanced deep brain stimulation (DBS) techniques for treating Parkinson's disease by analyzing the physiological mechanisms underlying burst-patterned stimulation of the globus pallidus internus (GPI). The research deliverables focus on mechanistic understanding of burst-DBS through analysis of basal-ganglia-thalamo-cortical motor network circuits using advanced intracranial recording techniques, including single-neuron dynamics, local field potentials, electrocorticography, and network physiology assessments. The project aims to identify optimal stimulation parameters and burst frequencies that produce sustained motor benefits while reducing the limitations of conventional fixed high-frequency DBS, including off-target side effects and device burden. This translational research addresses critical gaps in DBS optimization to improve clinical adoption and efficacy for patients with Parkinson's disease and represents a progression from the research team's pilot study demonstrating comparable efficacy and tolerability of burst-DBS versus conventional DBS approaches.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $110.1k | 4/21/26 | ||
| Not listed | $487.9k | 4/8/26 |